High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor

Our studies of the Bombyx mori ecdysone receptor (BE) revealed that, unlike the Drosophila melanogaster ecdysone receptor (DE), treatment of BE with the ecdysone agonist tebufenozide stimulated high level transactivation in mammalian cells without adding an exogenous heterodimer partner. Gel mobilit...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 95; no. 14; pp. 7999 - 8004
Main Authors: Suhr, S.T. (The Salk Institute for Biological Studies, La Jolla, CA.), Gil, E.B, Senut, M.C, Gage, F.H
Format: Journal Article
Language:English
Published: United States National Academy of Sciences of the United States of America 07-07-1998
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Our studies of the Bombyx mori ecdysone receptor (BE) revealed that, unlike the Drosophila melanogaster ecdysone receptor (DE), treatment of BE with the ecdysone agonist tebufenozide stimulated high level transactivation in mammalian cells without adding an exogenous heterodimer partner. Gel mobility shift and transfection assays with both the ultraspiracle gene product (Usp) and retinoid X receptor heterodimer partners indicated that this property of BE stems from significantly augmented heterodimer complex formation and concomitant DNA binding. We have mapped this "gain of function" to determinants within the D and E domains of BE and demonstrated that, although the D domain determinant is sufficient for high affinity heterodimerization with Usp, both determinants are necessary for high affinity interaction with retinoid X receptor. Modified BE receptors alone used as replication-defective retroviruses potently stimulated separate "reporter" viruses in all cell types examined, suggesting that BE has potentially broad utility in the modulation of transgene expression in mammalian cells
Bibliography:1999002857
L10
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
To whom reprint requests should be addressed. e-mail: Fgage@salk.edu.
Communicated by Michael G. Rosenfeld, University of California at San Diego, La Jolla, CA
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.95.14.7999